Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
Weihao Li(Sun Yat-sen University), Junzhong Lin(Sun Yat-sen University), Qingjian Ou(Sun Yat-sen University), Yanbo Xu(Sun Yat-sen University), Zhenlin Hou(Sun Yat-sen University), Jiahua He(University of California, San Francisco), Jianhong Peng(Sun Yat-sen University), Zhenhai Lu(Sun Yat-sen University), Long Yu(Fudan University), Lan Jin(Sun Yat-sen University), Xiaojun Wu(Sichuan University), Ling-Heng Kong(Sun Yat-sen University), Yujing Fang(Sun Yat-sen University), Chi Zhou(Sun Yat-sen University), Zhizhong Pan(Sun Yat-sen University), Huashan Liu(Sun Yat-sen University)
Cited by 387
Related Papers
The HDOCK server for integrated protein–protein docking
|Nature Protocols|2020|1.8k
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
|Nature Medicine|2019|367
Post-translational Modifications of Three Members of the Human MAP1LC3 Family and Detection of a Novel Type of Modification for MAP1LC3B
|Journal of Biological Chemistry|2003|271
Improvement of cryo-EM maps by simultaneous local and non-local deep learning
|Nature Communications|2023|209
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
|Viruses|2020|186